E2F1 promotes cancer cell sensitivity to cisplatin by regulating the cellular DNA damage response through miR-26b in esophageal squamous cell carcinoma

Cisplatin is an essential chemotherapy drug in esophageal squamous cell carcinoma (ESCC). Some studies suggested that the expression of E2F1 is increased in ESCC cells after cisplatin treatment, but its mechanism remains obscure. Here, we found that miR-26b is upregulated in ESCC cell lines with cis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kun, Zhang, Bo, Bai, Yun, Dai, Limeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930434/
https://www.ncbi.nlm.nih.gov/pubmed/31897226
http://dx.doi.org/10.7150/jca.33983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930434/
https://www.ncbi.nlm.nih.gov/pubmed/31897226
http://dx.doi.org/10.7150/jca.33983

Ejemplares similares